(Date:5/9/2008)..., The University of Leicester is leading on a nat... autism, it has been announced today. , Professo...artment of Health Sciences is spearheading the stu...including the the National Centre for Social Resea...Baron-Cohen of the Autism Research Centre. It wil...
(Date:5/9/2008)... GUANGZHOU, China, May 9 /Xinhua-PRNewswire/ -...CHME) (,China Medicine, or ,the,Company,), a l...nd over,the counter pharmaceuticals, traditional C...pplements, and medical devices and medical,formula...rence call at,10:00 a.m. Eastern Time on Monday, M...
(Date:5/9/2008)... ORLANDO, Fla., May 9 /PRNewswire-FirstCall/ -...r of pain-focused medical and surgical solutions a...ily withdraw its common,stock from listing on the ... of Directors considered several factors that incl...o timely file periodic reports with the Securi...
(Date:5/9/2008)... New Book Offers In-Depth Understanding of Femal... 9 /PRNewswire/ -- When the term "sexual,perpetrat...y typical,picture comes to mind for many people. M... perpetrator, but according to Dr. January Bishop,...g phenomenon, and the National,Criminal Census Bur...
Breaking Medicine News(10 mins):Health News:University of Leicester to lead audit of adults with autism 2Health News:University of Leicester to lead audit of adults with autism 3Health News:China Medicine Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:PainCare to Voluntarily Delist from American Stock Exchange 2Health News:PainCare to Voluntarily Delist from American Stock Exchange 3Health News:'Mommy Didn't Know': Female Sexual Offenders in the U.S. 2The Reusable Purse String Clamp is intended for use in the mechanical construction of a purse string suture. The clamp can be used on any part of the gastrointestinal tract except the esophagus.
ENDOPATH ILS Circular Sizer Set for ILS circular staplers. , ,The ILS Circular Sizer Set is intended to aid in selecting the appropriate size ILS Intraluminal Stapler for use in a variety of applica
...Single Use Biofragmentable Anastomosis Rings., ,...nd side-to-side anastomosis., ,VALTRAC™ Rin...anastomoses but not for gastric and esophageal ana...ocess for which intestinal resection and anastomos...
...rument to create an automatic purse-string with st...disposable instrument has application in intestina...gery for temporary and permanent purse-string plac...rument has application in intestinal, colorectal a...
Medicine Products:
(Date:5/7/2008)...y 7 /- Shire plc (LSE: SHP,...tical company, presented,today at a major scientif...,results of INTUNIV, a selective alpha-2A-agonist....dication, which is being evaluated for the,treatme...ity Disorder,(ADHD). The data demonstrated that IN...
(Date:5/7/2008)... N.J., May 7 /- Johnson & J...ancial analysts on Friday, May 9,at 4:00 p.m. (Eas...ety,s,(APS) annual meeting in Tampa, Fla. Phase 3 ...entadol immediate release (IR), a novel centrally ...irst time at APS., A pre-recorded Webcast, with t...
(Date:5/7/2008)...lif., May 7 /- New Phase 1,...xol) were presented by,Nektar Therapeutics (Nasdaq...merican Pain Society (APS) in Tampa, Florida. In t... shown to have substantial oral bioavailability,wi... is up to ten times the,known half-life of unPEGyl...
(Date:5/6/2008)...y Shows Benefits Differ from those in Adults-, ...ticosteroids given to,children who are hospitalize...t in survival or in reduced hospital stays, accord...archers. This finding stands in contrast,to previo...osteroids,dramatically reduced mortality., "Bec...
Breaking Medicine Technology:Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 2NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 3NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 4NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 5NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 6Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 2Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 3Why it is impossible for some to just say no 3328 1Why it is impossible for some to just say no 3328 2Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 3326 1Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 3326 2Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 3326 3Two Day Nurses Strike Begins Today 3324 1Two Day Nurses Strike Begins Today 3324 2Hazelden Honors Stephen I Sadove Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 3322 1Hazelden Honors Stephen I Sadove Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 3322 2Hazelden Honors Stephen I Sadove Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 3322 3...l/ -- Vical,Incorporated today announced that the ...ve results following interim analysis of data,from... of an,angiogenesis product candidate using Vical,...hat the primary efficacy,endpoint in the trial had...hat there were no major safety concerns related,to...
...one of the,first studies to compare the protectiv...n hypertensive patients with,diabetic nephropathy...ension, Milan. The results from this study show th...ntly greater extent,than losartan.(1) , ,Co...hills Hospital,in Calgary, Canada said "The AMADE...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5